London, June 11, 2026, 15:03 BST
- Beazley traded near 1,283p, little changed, as investors looked past the stock to Zurich’s most recent market moves and didn’t see a big new earnings story.
- Zurich reported buying 668,133 Beazley shares on June 10. That takes its holding to 27.1 million shares, or 4.50%.
- Traders are focused on the spread to the 1,310p cash leg in Zurich’s agreed bid, as court approval is still on track for the second half of 2026.
Beazley Plc shares stayed flat in London on Thursday, trading just above the previous close, while Zurich Insurance kept picking up Beazley stock even as the takeover waits for court approval. The stock opened at 1,283.5p, up half a penny from the June 10 close, according to London Stock Exchange data. Stockopedia logged Beazley unchanged at 1,283p, giving a market cap of around £7.72 billion.
Zurich’s newest Form 8 dealing disclosure, released Thursday, sparked the move. Zurich bought 77,851 Beazley shares at 1,282.5p, another 393,491 at 1,283p, and 196,791 at 1,283.5p on June 10. Altogether, Zurich picked up 668,133 shares, which comes out to about £8.57 million at those prices.
Zurich has shifted its position since the previous day. The earlier filing listed 26,407,866 Beazley shares, or 4.39%; now the total is 27,075,999 shares, or 4.50%. The percentage change is slight, but this matters for takeover watchers since Zurich keeps buying below the cash offer price set for the deal.
Beazley now trades more like a merger-arb play than an insurance name. The “spread” is the difference between its market price and what buyers expect to get if the Zurich deal closes. Zurich and Beazley struck a deal in March for a total value of 1,335p a share, which breaks down to 1,310p in cash plus a 25p allowed dividend.
Buyers looking at Beazley now are eyeing the 1,310p cash offer. The 25p dividend was paid on May 1, according to Beazley’s own announcement, so what’s left is the 27p spread between the current price and Zurich’s cash offer. Beazley trades at 1,283p, a gap of about 2.1% before factoring in completion risk or time value.
Deal spread remains open with the transaction still pending. Beazley shareholders backed the deal—99.91% of scheme shares voted for it at the April court meeting, and 99.92% at the general meeting. Reuters reported the nod from shareholders and also said the deal is still waiting for court approval, expected in the second half of 2026.
Legal approval is the next step. A scheme of arrangement is a UK court-driven process where a buyer can pick up all shares after shareholders and the court sign off. Beazley said the scheme still needs the Court’s sign-off at a hearing set for the second half of 2026. If the Court clears it, Beazley expects the scheme to take effect then.
Zurich’s daily buying is notable because it gives a running view of buyer demand. Still, the final outcome is not certain. The deal needs court approval and must clear other steps, with regulators like the PRA, FCA, Lloyd’s, FINMA and the European Commission all listed in the deal documents.
Beazley shares could see a steeper drop if the Zurich deal fails to close. Zurich offered 1,310p a share in cash, a 59.8% premium over Beazley’s 820p finish on January 16, the trading day before the deal period started. If the offer falls through, investors would need to rethink Beazley’s value without the buyout premium, though the specialty insurance business would still hold strategic appeal.
Approvals and court dates are now in focus for Zurich after it raised 3.9 billion Swiss francs in March by selling shares to help pay for the Beazley deal, Reuters reports. The rest should come from its own cash and debt. Investors are also watching if Zurich keeps buying at these levels.
The next thing traders are waiting for is either another regulatory statement on the scheme’s timing or a fresh Form 8 disclosure. That will show if Zurich is still adding Beazley shares under the 1,310p cash offer.
